A carregar...

Reimbursement for bone loss prevention is different between women with breast cancer and men with prostate cancer: time for a revision

The hormone dependent breast and prostate cancers have in general a very good survival, due to the anti-hormonal treatment. A disadvantage of this treatment is the increased risk of osteoporosis and fractures. It is surprisingly to note that denosumab has the same impact on fracture reduction incide...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Facts Views Vis Obgyn
Autor principal: Tjalma, W.A.A.
Formato: Artigo
Idioma:Inglês
Publicado em: Universa Press 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4788334/
https://ncbi.nlm.nih.gov/pubmed/26977268
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!